EC Number   |
Application |
Reference |
|---|
   3.4.22.1 | biotechnology |
inhibition of cathepsin B greatly improves the developmental competence of bovine oocytes and increases the number of high-quality embryos |
710021 |
| 3.4.22.1 | diagnostics |
CATB is a potent and independent prognostic marker for resectable pancreatic adenocarcinoma |
697083 |
| 3.4.22.1 | diagnostics |
cathepsin B activity can be a useful marker of oocyte quality |
710021 |
| 3.4.22.1 | diagnostics |
cathepsin B is a biologic marker reflecting the clinical state of inflammatory disease |
695447 |
| 3.4.22.1 | diagnostics |
cathepsin B is a possible prognostic biomarker for the aggressiveness of ovarian cancer, overview |
709209 |
| 3.4.22.1 | diagnostics |
cathepsin B is an important biomarker for the stratification of glioblastoma patients with respect to survival |
707002 |
| 3.4.22.1 | diagnostics |
increased cathepsin-B expression is predictive of more aggressive tumour behaviour over time and can be regarded as an unfavourable and independent tumour marker for endometrial cancer patients with a long follow-up |
698146 |
| 3.4.22.1 | diagnostics |
the enzyme might be a useful marker for cancer development |
697710 |
| 3.4.22.1 | drug development |
cathepsin B contributes to the neovascularization process and should be considered as a potential therapeutic target |
669599 |
| 3.4.22.1 | drug development |
cathepsin B could be a drug target for several pathologies, based mainly on its role in cancer progression and osteoarthritis in humans |
696540 |
